Ann: Investor Webinar, page-63

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 63 Last

Share
Profile

Follow
maria1240

323 Posts.

160

18/06/22

12:26

Post #: 62070637
Share

Originally posted by gedck ↑

I pretty much agree Rusty.

My take (IMO):

TK is completely exhausted and burnt out.

It seems pretty clear that the new line those in higher places have decided to push, in addition to the "share price premium blah blah" rhetoric, is to highlight the "risks" of moving forward "alone" - in a clear and blatant attempt to create enough fear among shareholders to sell.

One thing that I felt very contradictory - TK was highlighting the "risks" of advancing forward, and lack of resources at hand to achieve this etc. etc. Only to then highlight that Pfizer do not have such risks or lack of resources (obviously given who they are) etc. etc.

How is it in the shareholders best interests then to sell to Pfizer? Surely it is in our best interests to establish some sort of partnership, so our company can leverage their resources to commercialise our technology???

I think we as shareholders really need a leader with energy, confidence, and capacity to effectively negotiate what is actually in our best interests.

I do not have faith (nor trust now unfortunately) that our BOD have our best interests in mind, or have the professional competence to negotiate at the "level" required to deal with such large entities. This has also been a weakness in the past I feel.

i really do hope that we as shareholders keep banding together to vote NO.

Expand

Have said it before, 50c is the minimum for us to vote yes. Anything below that, will be a no, even if we are the last one standing. Retail holders need to stick together to fight this all along.

RAP Price at posting: 17.5¢ Sentiment: Hold Disclosure: Held
16 Upvote

0 Great analysis

Reply

Top Stories

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 56 more messages in this thread...

First 63 Last

Add RAP (ASX) to my watchlist

Ann: Investor Webinar, page-63

Top Stories

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News